Transforming mental health
Our lead drug candidate is a fixed dose combination of an SSRI and a micro-dose of ibogaine - psychoactive stimulant
Ibogaine is a psychoactive compound originally isolated from the root bark of the iboga tree (Tabernanthe iboga) in central and west Africa.
It was sold in Franc as a stimulant drug up to the 1970’s under the name Lambarène
It is currently being developed in the US as an anti-addiction drug